212 related articles for article (PubMed ID: 21478262)
1. Complement dependency of cardiomyocyte release of mediators during sepsis.
Atefi G; Zetoune FS; Herron TJ; Jalife J; Bosmann M; Al-Aref R; Sarma JV; Ward PA
FASEB J; 2011 Jul; 25(7):2500-8. PubMed ID: 21478262
[TBL] [Abstract][Full Text] [Related]
2. Functional roles for C5a receptors in sepsis.
Rittirsch D; Flierl MA; Nadeau BA; Day DE; Huber-Lang M; Mackay CR; Zetoune FS; Gerard NP; Cianflone K; Köhl J; Gerard C; Sarma JV; Ward PA
Nat Med; 2008 May; 14(5):551-7. PubMed ID: 18454156
[TBL] [Abstract][Full Text] [Related]
3. An essential role for complement C5a in the pathogenesis of septic cardiac dysfunction.
Niederbichler AD; Hoesel LM; Westfall MV; Gao H; Ipaktchi KR; Sun L; Zetoune FS; Su GL; Arbabi S; Sarma JV; Wang SC; Hemmila MR; Ward PA
J Exp Med; 2006 Jan; 203(1):53-61. PubMed ID: 16380509
[TBL] [Abstract][Full Text] [Related]
4. The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation.
Bosmann M; Haggadone MD; Zetoune FS; Sarma JV; Ward PA
Eur J Immunol; 2013 Jul; 43(7):1907-13. PubMed ID: 23575697
[TBL] [Abstract][Full Text] [Related]
5. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a functional role of the second C5a receptor C5L2.
Gao H; Neff TA; Guo RF; Speyer CL; Sarma JV; Tomlins S; Man Y; Riedemann NC; Hoesel LM; Younkin E; Zetoune FS; Ward PA
FASEB J; 2005 Jun; 19(8):1003-5. PubMed ID: 15784721
[TBL] [Abstract][Full Text] [Related]
7. C5L2: a controversial receptor of complement anaphylatoxin, C5a.
Li R; Coulthard LG; Wu MC; Taylor SM; Woodruff TM
FASEB J; 2013 Mar; 27(3):855-64. PubMed ID: 23239822
[TBL] [Abstract][Full Text] [Related]
8. Complement-induced activation of MAPKs and Akt during sepsis: role in cardiac dysfunction.
Fattahi F; Kalbitz M; Malan EA; Abe E; Jajou L; Huber-Lang MS; Bosmann M; Russell MW; Zetoune FS; Ward PA
FASEB J; 2017 Sep; 31(9):4129-4139. PubMed ID: 28572445
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
10. C5a-blockade improves burn-induced cardiac dysfunction.
Hoesel LM; Niederbichler AD; Schaefer J; Ipaktchi KR; Gao H; Rittirsch D; Pianko MJ; Vogt PM; Sarma JV; Su GL; Arbabi S; Westfall MV; Wang SC; Hemmila MR; Ward PA
J Immunol; 2007 Jun; 178(12):7902-10. PubMed ID: 17548628
[TBL] [Abstract][Full Text] [Related]
11. Complement C5a receptors C5L2 and C5aR in renal fibrosis.
Martin IV; Bohner A; Boor P; Shagdarsuren E; Raffetseder U; Lammert F; Floege J; Ostendorf T; Weber SN
Am J Physiol Renal Physiol; 2018 Jan; 314(1):F35-F46. PubMed ID: 28903945
[TBL] [Abstract][Full Text] [Related]
12. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans.
Huber-Lang M; Sarma JV; Rittirsch D; Schreiber H; Weiss M; Flierl M; Younkin E; Schneider M; Suger-Wiedeck H; Gebhard F; McClintock SD; Neff T; Zetoune F; Bruckner U; Guo RF; Monk PN; Ward PA
J Immunol; 2005 Jan; 174(2):1104-10. PubMed ID: 15634936
[TBL] [Abstract][Full Text] [Related]
13. C5a regulates NKT and NK cell functions in sepsis.
Fusakio ME; Mohammed JP; Laumonnier Y; Hoebe K; Köhl J; Mattner J
J Immunol; 2011 Dec; 187(11):5805-12. PubMed ID: 22058413
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of C5a receptor in mouse microvascular endothelial cells.
Laudes IJ; Chu JC; Huber-Lang M; Guo RF; Riedemann NC; Sarma JV; Mahdi F; Murphy HS; Speyer C; Lu KT; Lambris JD; Zetoune FS; Ward PA
J Immunol; 2002 Nov; 169(10):5962-70. PubMed ID: 12421982
[TBL] [Abstract][Full Text] [Related]
15. High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques.
Vijayan S; Asare Y; Grommes J; Soehnlein O; Lutgens E; Shagdarsuren G; Togtokh A; Jacobs MJ; Fischer JW; Bernhagen J; Weber C; Schober A; Shagdarsuren E
Am J Pathol; 2014 Jul; 184(7):2123-33. PubMed ID: 24819959
[TBL] [Abstract][Full Text] [Related]
16. γδT-cell function in sepsis is modulated by C5a receptor signalling.
Han G; Geng S; Li Y; Chen G; Wang R; Li X; Ma Y; Shen B; Li Y
Immunology; 2011 Jul; 133(3):340-9. PubMed ID: 21501163
[TBL] [Abstract][Full Text] [Related]
17. C5L2 is required for C5a-triggered receptor internalization and ERK signaling.
Hsu WC; Yang FC; Lin CH; Hsieh SL; Chen NJ
Cell Signal; 2014 Jul; 26(7):1409-19. PubMed ID: 24631530
[TBL] [Abstract][Full Text] [Related]
18. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.
Kalbitz M; Fattahi F; Grailer JJ; Jajou L; Malan EA; Zetoune FS; Huber-Lang M; Russell MW; Ward PA
FASEB J; 2016 Dec; 30(12):3997-4006. PubMed ID: 27543123
[TBL] [Abstract][Full Text] [Related]
19. MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.
Bosmann M; Patel VR; Russkamp NF; Pache F; Zetoune FS; Sarma JV; Ward PA
FASEB J; 2011 Dec; 25(12):4222-32. PubMed ID: 21859896
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine kinase 1 mediation of expression of the anaphylatoxin receptor C5L2 dampens the inflammatory response to endotoxin.
Bachmaier K; Guzman E; Kawamura T; Gao X; Malik AB
PLoS One; 2012; 7(2):e30742. PubMed ID: 22355325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
